Design strategies for global clinical trials of endovascular devices for critical limb ischemia (CLI) ― A joint USA-Japanese perspectiv

Hiroyoshi Yokoi, Mami Ho, Shin Iwamoto, Yuka Suzuki, Gary M. Ansel, Nobuyoshi Azuma, Nobuhiro Handa, Osamu Iida, Koji Ikeda, Fumiaki Ikeno, Norihiko Ohura, Kenneth Rosenfield, John Rundback, Hiroto Terashi, Takahiro Uchida, Yoshiaki Yokoi, Masato Nakamura, Michael R. Jaff

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

For more than 10 years, the Harmonization by Doing (HBD) program, a joint effort by members from academia, industry and regulators from the United States of America (USA) and Japan, has been working to increase timely regulatory approval for cardiovascular devices through the development of practical global clinical trial paradigms. Consistent with this mission and in recognition of the increasing global public health effects of critical limb ischemia (CLI), academic and government experts from the USA and Japan have developed a basic framework of global clinical trials for endovascular devices for CLI. Despite differences in medical and regulatory environments and complex patient populations in both countries, we developed a pathway for the effective design and conduct of global CLI device studies by utilizing common study design elements such as patients’ characteristics and study endpoints, and minimizing the effect of important clinical differences. Some of the key recommendations for conducting global CLI device studies are: including patients on dialysis; using a composite primary endpoint for effectiveness that includes 6-month post-procedure therapeutic success and target vessel patency; and using a 30-day primary safety endpoint of perioperative death and major adverse limb events. The proposed approach will be uniquely beneficial in facilitating both the initiation and interpretation of CLI studies and accelerating worldwide CLI device development and innovation.

Original languageEnglish
Pages (from-to)2233-2239
Number of pages7
JournalCirculation Journal
Volume82
Issue number9
DOIs
Publication statusPublished - 2018

Keywords

  • Critical limb ischemia
  • Endovascular devices
  • Global clinical trials
  • Harmonization by doing

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Design strategies for global clinical trials of endovascular devices for critical limb ischemia (CLI) ― A joint USA-Japanese perspectiv'. Together they form a unique fingerprint.

  • Cite this

    Yokoi, H., Ho, M., Iwamoto, S., Suzuki, Y., Ansel, G. M., Azuma, N., Handa, N., Iida, O., Ikeda, K., Ikeno, F., Ohura, N., Rosenfield, K., Rundback, J., Terashi, H., Uchida, T., Yokoi, Y., Nakamura, M., & Jaff, M. R. (2018). Design strategies for global clinical trials of endovascular devices for critical limb ischemia (CLI) ― A joint USA-Japanese perspectiv. Circulation Journal, 82(9), 2233-2239. https://doi.org/10.1253/circj.CJ-18-0014